{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T08:40:28Z","timestamp":1729240828967,"version":"3.27.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Youth Project of Natural Science Foundation of Shandong Province","award":["ZR2022QH187"],"award-info":[{"award-number":["ZR2022QH187"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-024-01460-9","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T08:02:45Z","timestamp":1729238565000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility of an artificial intelligence system for tumor response evaluation"],"prefix":"10.1186","volume":"24","author":[{"given":"Nie","family":"Xiuli","sequence":"first","affiliation":[]},{"given":"Chen","family":"Hua","sequence":"additional","affiliation":[]},{"given":"Gao","family":"Peng","sequence":"additional","affiliation":[]},{"given":"Yu","family":"Hairong","sequence":"additional","affiliation":[]},{"given":"Sun","family":"Meili","sequence":"additional","affiliation":[]},{"given":"Yan","family":"Peng","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"1460_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, Ford R, Gwyther S, Mandrekar S, et al. RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer. 2016;62:132\u20137.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1460_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"key":"1460_CR3","doi-asserted-by":"crossref","unstructured":"Ko CC, Yeh LR, Kuo YT, Chen JH. Imaging biomarkers for evaluating tumor response: RECIST and beyond. Biomark Res. 2021;9(1):52.","DOI":"10.1186\/s40364-021-00306-8"},{"issue":"11","key":"1460_CR4","doi-asserted-by":"publisher","first-page":"e040096","DOI":"10.1136\/bmjopen-2020-040096","volume":"10","author":"M Woo","year":"2020","unstructured":"Woo M, Heo M, Devane AM, Lowe SC, Gimbel RW. Retrospective comparison of approaches to evaluating inter-observer variability in CT tumour measurements in an academic health centre. BMJ Open. 2020;10(11):e040096.","journal-title":"BMJ Open"},{"issue":"22","key":"1460_CR5","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1200\/JCO.2008.16.1711","volume":"26","author":"LE Dodd","year":"2008","unstructured":"Dodd LE, Korn EL, Freidlin B, Jaffe CC, Rubinstein LV, Dancey J, et al. Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense. J Clin Oncol. 2008;26(22):3791\u20136.","journal-title":"J Clin Oncol"},{"issue":"26","key":"1460_CR6","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1056\/NEJMoa064320","volume":"355","author":"CE Geyer","year":"2006","unstructured":"Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med. 2006;355(26):2733\u201343.","journal-title":"N Engl J Med"},{"issue":"4","key":"1460_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1200\/JCO.2005.05.098","volume":"23","author":"KD Miller","year":"2005","unstructured":"Miller KD, Chap LI, Holmes FA, Cobleigh MA, Marcom PK, Fehrenbacher L, et al. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol. 2005;23(4):792\u20139.","journal-title":"J Clin Oncol"},{"issue":"33","key":"1460_CR8","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1200\/JCO.2007.12.6557","volume":"25","author":"ES Thomas","year":"2007","unstructured":"Thomas ES, Gomez HL, Li RK, Chung HC, Fein LE, Chan VF, et al. Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol. 2007;25(33):5210\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1460_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2478\/v10019-012-0009-z","volume":"46","author":"D Muenzel","year":"2012","unstructured":"Muenzel D, Engels HP, Bruegel M, Kehl V, Rummeny EJ, Metz S. Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1. Radiol Oncol. 2012;46(1):8\u201318.","journal-title":"Radiol Oncol"},{"issue":"5","key":"1460_CR10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00330-010-2013-2","volume":"21","author":"L Dubus","year":"2011","unstructured":"Dubus L, Gayet M, Zappa M, Abaleo L, De Cooman A, Orieux G, et al. Comparison of semi-automated and manual methods to measure the volume of liver tumours on MDCT images. Eur Radiol. 2011;21(5):996\u20131003.","journal-title":"Eur Radiol"},{"issue":"12","key":"1460_CR11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1136\/thoraxjnl-2021-217808","volume":"77","author":"AC Kidd","year":"2022","unstructured":"Kidd AC, Anderson O, Cowell GW, Weir AJ, Voisey JP, Evison M, et al. Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria. Thorax. 2022;77(12):1251\u20139.","journal-title":"Thorax"},{"issue":"14","key":"1460_CR12","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1158\/1078-0432.CCR-05-0109","volume":"11","author":"HI Scher","year":"2005","unstructured":"Scher HI, Morris MJ, Kelly WK, Schwartz LH, Heller G. Prostate cancer clinical trial end points: RECISTing a step backwards. Clin Cancer Res. 2005;11(14):5223\u201332.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1460_CR13","doi-asserted-by":"publisher","first-page":"CNS28","DOI":"10.2217\/cns-2018-0007","volume":"8","author":"UN Chukwueke","year":"2019","unstructured":"Chukwueke UN, Wen PY. Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice. CNS Oncol. 2019;8(1):CNS28.","journal-title":"CNS Oncol"},{"key":"1460_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.7150\/jca.1.80","volume":"1","author":"CM Costelloe","year":"2010","unstructured":"Costelloe CM, Chuang HH, Madewell JE, Ueno NT. Cancer Response Criteria and Bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer. 2010;1:80\u201392.","journal-title":"J Cancer"},{"issue":"2","key":"1460_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004;15(2):257\u201360.","journal-title":"Ann Oncol"},{"issue":"23","key":"1460_CR16","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1200\/JCO.2010.33.7071","volume":"29","author":"GR Oxnard","year":"2011","unstructured":"Oxnard GR, Zhao B, Sima CS, Ginsberg MS, James LP, Lefkowitz RA, et al. Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes. J Clin Oncol. 2011;29(23):3114\u20139.","journal-title":"J Clin Oncol"},{"key":"1460_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1471-2407-13-193","volume":"13","author":"DJ Stewart","year":"2013","unstructured":"Stewart DJ, Kurzrock R. Fool\u2019s gold, lost treasures, and the randomized clinical trial. BMC Cancer. 2013;13:193.","journal-title":"BMC Cancer"},{"issue":"5","key":"1460_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4143\/crt.2005.37.5.290","volume":"37","author":"JH Choi","year":"2005","unstructured":"Choi JH, Ahn MJ, Rhim HC, Kim JW, Lee GH, Lee YY, et al. Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma. Cancer Res Treat. 2005;37(5):290\u20133.","journal-title":"Cancer Res Treat"},{"issue":"12","key":"1460_CR19","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1200\/JCO.1997.15.12.3507","volume":"15","author":"P Thiesse","year":"1997","unstructured":"Thiesse P, Ollivier L, Di Stefano-Louineau D, N\u00e9grier S, Savary J, Pignard K, et al. Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Fran\u00e7ais d\u2019Immunoth\u00e9rapie of the F\u00e9d\u00e9ration Nationale Des Centres de Lutte Contre Le Cancer. J Clin Oncol. 1997;15(12):3507\u201314.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1460_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.23736\/S1824-4785.17.03038-2","volume":"62","author":"S Grimaldi","year":"2018","unstructured":"Grimaldi S, Terroir M, Caramella C. Advances in oncological treatment: limitations of RECIST 1.1 criteria. Q J Nucl Med Mol Imaging. 2018;62(2):129\u201339.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"7676","key":"1460_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature24270","volume":"550","author":"D Silver","year":"2017","unstructured":"Silver D, Schrittwieser J, Simonyan K, Antonoglou I, Huang A, Guez A, et al. Mastering the game of Go without human knowledge. Nature. 2017;550(7676):354\u20139.","journal-title":"Nature"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-024-01460-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T08:03:58Z","timestamp":1729238638000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-024-01460-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1186\/s12880-024-01460-9","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the tenets of the Declaration of Helsinki and was approved by the Jinan Central Hospital, Shandong First Medical University Clinical Human Research Ethics Committee. All participants provided written informed consent to have their images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}